Serving hundreds of leading biopharmaceutical companies globally:

Generated: November 14, 2018

DrugPatentWatch Database Preview

Leo Labs Company Profile

« Back to Dashboard

What is the competitive landscape for LEO LABS, and what generic alternatives to LEO LABS drugs are available?

LEO LABS has one approved drug.

There are sixteen US patents protecting LEO LABS drugs.

Summary for Leo Labs

US Patents:	16
Tradenames:	1
Ingredients:	1
NDAs:	1

Drugs and US Patents for Leo Labs

+ Get email alerts for changes to this table

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Leo Labs	PICATO	ingenol mebutate	GEL;TOPICAL	202833-002	Jan 23, 2012		RX	Yes	Yes	7,410,656	➤ Sign Up				➤ Sign Up
Leo Labs	PICATO	ingenol mebutate	GEL;TOPICAL	202833-001	Jan 23, 2012		RX	Yes	Yes	8,716,271	➤ Sign Up				➤ Sign Up
Leo Labs	PICATO	ingenol mebutate	GEL;TOPICAL	202833-002	Jan 23, 2012		RX	Yes	Yes	8,536,163	➤ Sign Up				➤ Sign Up
Leo Labs	PICATO	ingenol mebutate	GEL;TOPICAL	202833-002	Jan 23, 2012		RX	Yes	Yes	8,377,919	➤ Sign Up	Y			➤ Sign Up
Leo Labs	PICATO	ingenol mebutate	GEL;TOPICAL	202833-001	Jan 23, 2012		RX	Yes	Yes	6,844,013	➤ Sign Up				➤ Sign Up
Leo Labs	PICATO	ingenol mebutate	GEL;TOPICAL	202833-001	Jan 23, 2012		RX	Yes	Yes	8,735,375	➤ Sign Up				➤ Sign Up
Leo Labs	PICATO	ingenol mebutate	GEL;TOPICAL	202833-002	Jan 23, 2012		RX	Yes	Yes	9,861,603	➤ Sign Up				➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

Expired US Patents for Leo Labs

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Leo Labs	PICATO	ingenol mebutate	GEL;TOPICAL	202833-001	Jan 23, 2012	6,432,452	➤ Sign Up
Leo Labs	PICATO	ingenol mebutate	GEL;TOPICAL	202833-002	Jan 23, 2012	6,787,161	➤ Sign Up
Leo Labs	PICATO	ingenol mebutate	GEL;TOPICAL	202833-002	Jan 23, 2012	6,432,452	➤ Sign Up
Leo Labs	PICATO	ingenol mebutate	GEL;TOPICAL	202833-001	Jan 23, 2012	6,787,161	➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration

Paragraph IV (Patent) Challenges for LEO LABS drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Gel	0.05%	➤ Subscribe	2016-01-27

International Patents for Leo Labs Drugs

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Country	Document Number	Estimated Expiration
World Intellectual Property Organization (WIPO)	9908994	➤ Sign Up
New Zealand	569197	➤ Sign Up
European Patent Office	2399571	➤ Sign Up
Australia	736230	➤ Sign Up
Hungary	228862	➤ Sign Up
Canada	2301082	➤ Sign Up
Australia	8721798	➤ Sign Up
Country	Document Number	Estimated Expiration

Supplementary Protection Certificates for Leo Labs Drugs

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
2014030	Lithuania	➤ Sign Up	PRODUCT NAME: INGENOLI MEBUTATUM; REGISTRATION NO/DATE: EU/1/'12/796/001, 2012 11 15 EU/1/12/796/002 20121115
2013 00024	Denmark	➤ Sign Up
2014 00042	Denmark	➤ Sign Up	PRODUCT NAME: INGENOLMEBUTAT ELLER ET DERIVAT (SALT ELLER ESTER) DERAF); REG. NO/DATE: EU/1/12/796/001-002 20121115
0682	Netherlands	➤ Sign Up	PRODUCT NAME: INGENOLMEBUTAAT OF EEN DERIVAAT (ZOUT OF ESTER) DAARVAN; REGISTRATION NO/DATE: EU/1/12/796 20121119
00592	Netherlands	➤ Sign Up	PRODUCT NAME: INGENAN OF EEN DERIVAAT (ZOUT OF ESTER) DAARVAN; REGISTRATION NO/DATE: EU/1/12/796/001-002 20121115
5	Finland	➤ Sign Up
0140025 00111	Estonia	➤ Sign Up	PRODUCT NAME: INGENOOLMEBUTAAT;REG NO/DATE: K(2012)8481 (LOPLIK) 19.11.2012
Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow

McKesson

Fuji

QuintilesIMS

AstraZeneca

Covington

Cerilliant

McKinsey

Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.